 Home > Medical News > Latest Medical News > Hutchison Medicine announces that Sofatinib is approved for the treatment of advanced pancreatic neuroendocrine tumors

Hutchison Medicine announces that Sofatinib is approved for the treatment of advanced pancreatic neuroendocrine tumors

 Last Update: 2021-08-11
 Source: Internet
 Author: User

Tags

chinese food freeport

dmt drug street name

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

Hutchison Pharmaceuticals (Nasdaq/London Stock Exchange: HCM) today announced that Sofatinib has been officially approved by the China National Medical Products Administration ("SFDA") for the treatment of advanced pancreatic neuroendocrine tumors (pNETs)

The company learned through the website of the State Food and Drug Administration that the registration and approval of Sofantinib for the treatment of pancreatic neuroendocrine tumors has been completed, and the approval document is under preparation

Mr.

Sofatinib is sold in the Chinese market under the trade name Sutaida® (English trademark: Sulanda®)

Hutchison Medical's oncology specialist commercialization team currently covers more than 2,500 hospitals in China

The approval of the National Food and Drug Administration is based on the results of a Chinese phase III clinical trial SANET-p (clinicaltrials.

China is estimated to have approximately 71,300 newly diagnosed cases of neuroendocrine tumors in 2020

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

L-Ascorbate-2-Monophosphate Feed Grade

CAS No.: 109620-90-8

Feed Grade

Potassium Sorbate from reliable manufacturer

CAS No.: 590-00-1

Food Grade

Doxycycline Hydrochloride

CAS No.: 10592-13-9

Pharmaceutical Grade

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

announcements today(81)

80 20 company(94)

united states logo(227)

single use technology(195)

healthy food name(42)

ups united states(221)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.